ETX101
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ETX101, covering 2025-11-14 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome [Phase 1, Phase 2]